Journal of ethnopharmacology · 2025
Anti-metastatic and anti-tumor effects of the ethyl acetate fraction of Ajwa dates (Phoenix dactylifera L.) in prostate cancer models and its UPLC-based phytochemical profiling.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Baig Mirza Muqtadir, Quadri Syed Fareeduddin, Nur Abdulkadir Kurban, Mohammed Furkhan Ahmed, Begum Syeda Hajera, Shafi Heeba Mohammed, Shafiuddin Huda Mohammad, Elkady Ayman I, Khan Aleem Ahmed
Аннотация
ETHNOPHARMACOLOGICAL RELEVANCE: The Al Madina Al Munawwara variety of Phoenix dactylifera L. (Ajwa dates) is a date fruit of cultural, religious, and medicinal significance. Traditionally used in prophetic and alternative medicine, Ajwa dates are reported to possess anti-inflammatory, antioxidant, and anti-cancer properties. However, the role of Ajwa dates in targeting prostate cancer metastasis remains underexplored.
AIM OF THE STUDY: To evaluate the anti-metastatic and anti-tumor properties of the ethyl acetate fraction of Ajwa dates (EAFAD) against prostate cancer stem-like cells (PC3) in vitro and in vivo, and to identify its bioactive compounds using Ultra-Performance Liquid Chromatography (UPLC).
MATERIALS AND METHODS: PC3 cells were cultured in ultra-low attachment plates to enrich stem-like cells, confirmed by chemoresistance and toluidine blue staining. EAFAD was evaluated for cytotoxicity (MTT assay), anti-migratory activity (wound-healing, migration, and invasion assays), and anti-tumor efficacy using a xenograft mouse model. UPLC analysis identified bioactive compounds in EAFAD.
RESULTS: Cancer stem-like cells were enriched, and tumorspheres were formed. EAFAD inhibited the proliferation, migration, and invasive properties of stem-like PC3 cells. The in vivo model showed suppressed tumor growth in the EAFAD-treated group, and histopathological analysis confirmed tumor cell apoptosis. The UPLC analysis of EAFAD confirmed the presence of compounds, including methyl 4-acetoxybenzoate, 2-hydroxycinnamic acid, diosmin, and isorhamnetin-3-O-glucoside, some of which are known for their anticancer and anti-inflammatory activities.
CONCLUSION: EAFAD exhibited potent in vitro anti-proliferative effects against stem-like PC3 cells. It also demonstrated anti-migratory, anti-invasive effects and notable in vivo anti-tumor activity. These results indicate that EAFAD could serve as a potential therapeutic agent for prostate cancer.
AIM OF THE STUDY: To evaluate the anti-metastatic and anti-tumor properties of the ethyl acetate fraction of Ajwa dates (EAFAD) against prostate cancer stem-like cells (PC3) in vitro and in vivo, and to identify its bioactive compounds using Ultra-Performance Liquid Chromatography (UPLC).
MATERIALS AND METHODS: PC3 cells were cultured in ultra-low attachment plates to enrich stem-like cells, confirmed by chemoresistance and toluidine blue staining. EAFAD was evaluated for cytotoxicity (MTT assay), anti-migratory activity (wound-healing, migration, and invasion assays), and anti-tumor efficacy using a xenograft mouse model. UPLC analysis identified bioactive compounds in EAFAD.
RESULTS: Cancer stem-like cells were enriched, and tumorspheres were formed. EAFAD inhibited the proliferation, migration, and invasive properties of stem-like PC3 cells. The in vivo model showed suppressed tumor growth in the EAFAD-treated group, and histopathological analysis confirmed tumor cell apoptosis. The UPLC analysis of EAFAD confirmed the presence of compounds, including methyl 4-acetoxybenzoate, 2-hydroxycinnamic acid, diosmin, and isorhamnetin-3-O-glucoside, some of which are known for their anticancer and anti-inflammatory activities.
CONCLUSION: EAFAD exhibited potent in vitro anti-proliferative effects against stem-like PC3 cells. It also demonstrated anti-migratory, anti-invasive effects and notable in vivo anti-tumor activity. These results indicate that EAFAD could serve as a potential therapeutic agent for prostate cancer.